Results 31 to 40 of about 981,607 (247)

THE RESULTS OF MECHANICAL HEART SUPPORT SYSTEMS «INCOR» IMPLANTATION

Вестник трансплантологии и искусственных органов, 2014
The aim of investigation isestimation of mechanical heart support system «INCOR» implantation efficacy. Materials and methods. The Institute of Circulation Pathology has clinical experience of mechanical circulatory support systems «INCOR» (Berlin Heart ...
A. M. Cherniavskiy, A. M. Karaskov, D. V. Doronin, M. N. Deryagin, A. V. Fomichev   +4 more
doaj   +1 more source

RESULTS OF INTRAMYOCARDIAL ADMINISTRATION OF A MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW CELLS IN CHD PATIENTS WITH CONCOMITANT CARDIAINSUFFICIENCY

Вестник трансплантологии и искусственных органов, 2013
Aim. Evaluation of long-term results of drug therapy and intramyocardial administration of a mononuclear fraction of bone marrow cells in CHD patients with chronic cardiac insufficiency. Materials and methods. 109 patients were randomized into two groups
A. M. Cherniavsky, Ye. N. Kliever, Ye. A. Pokushalov, A. B. Romanov, I. N. Terekhov, Ye. E. Kliever   +5 more
doaj   +1 more source

Blood Group Types O and Non-O Are Associated With Coronary Collateral Circulation Development

Clinical and Applied Thrombosis/Hemostasis, 2020
Blood group types are associated with coronary artery disease. However, data are scarce about the impact of blood group types on coronary collateral circulation.
Savas Celebi MD, Ozlem Ozcan Celebi MD, Berkten Berkalp MD, Sinan Aydogdu MD, Basri Amasyali MD   +4 more
doaj   +1 more source

Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: Prospective, population based study of British men [PDF]

, 2005
Objective: To examine trends over time in rates of different forms of diagnosed coronary heart disease among British men, during a period in which mortality due to coronary heart disease has been declining.
Morris, RW, Lampe, Fiona C, Lampe, FC, Walker, Mary, Whincup, Peter H, Whincup, PH, Morris, Richard W, Walker, M, Gerald Shaper, A, Shaper, A Gerald   +9 more
core   +1 more source

Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications [PDF]

, 2001
Objectives: To assess whether patients with heart disease in a single UK hospital have equitable access to exercise testing, coronary angiography, and coronary artery bypass graft surgery (CABG).Method: Retrospective analysis of patients' medical case ...
Bowling, A., Blackman, I, McKee, D, McClay, M, Banning, A P, Martin, A, McKee, D., A Bowling, McClay, M., Banning, AP, Martin, A., Bond, M., Blackman, I., Dudley, N, Banning, A.P., Dudley, N., Bond, M, Elder, A, Elder, A., Bowling, A   +19 more
core   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

FEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin, Naghme Radmannia, David N. Huynh, Liliane Ménard, Caroline Daneault, Maïté Veilleux, Ahsanullah Ahsanullah, André C. Carpentier, William D. Lubell, Matthieu Ruiz, Huy Ong, Sylvie Marleau, Simon‐Pierre Gravel   +12 more
wiley   +1 more source

Coffee consumption and coronary calcification: The Rotterdam coronary calcification study [PDF]

, 2008
BACKGROUND - The role of coffee in the cardiovascular system is not yet clear. We examined the relation of coffee intake with coronary calcification in a population-based cohort.
Hofman, A. (Albert), Witteman, JCM, Matthijs Oudkerk, Vliegenthart, R. (Rozemarijn), Hofman, Albert, Albert Hofman, Hofman, Bert, Oudkerk, M. (Matthijs), Geertruida J. van Woudenbergh, van Rooij, FJA; id_orcid, Geleijnse, J.M., Vliegenthart, R (Rozemarijn), Geleijnse, J.M. (Marianne), Rooij, F.J.A. (Frank) van, Vliegenthart, R., Rozemarijn Vliegenthart, Jacqueline C.M. Witteman, Rooij, F.J.A., van, Geleijnse, Johanna M., Witteman, J.C.M. (Jacqueline), van Rooij, Frank J. A., Geleijnse, JM (Marianne), Witteman, J.C.M., Oudkerk, Matthijs; id_orcid, Johanna M. Geleijnse, Hofman, A., van Woudenbergh, Geertruida J., van Woudenbergh, G.J., Woudenbergh, G.J., van, Woudenbergh, G.J. (Geertruida) van, van Rooij, F.J.A., van Woudenbergh, GJ, Oudkerk, Matthijs, Witteman, Jacqueline C. M., Vliegenthart, Rozemarijn, Oudkerk, M., Frank J.A. van Rooij, Oudkerk, M   +37 more
core   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Reprogramming the myocardial infarction microenvironment with melanin-based composite nanomedicines in mice

Nature Communications
Myocardial infarction (MI) has a 5-year mortality rate of more than 50% due to the lack of effective treatments. Interactions between cardiomyocytes and the MI microenvironment (MIM) can determine the progression and fate of infarcted myocardial tissue ...
Yamei Liu, Shuya Wang, Jiaxiong Zhang, Quan Sun, Yi Xiao, Jing Chen, Meilian Yao, Guogang Zhang, Qun Huang, Tianjiao Zhao, Qiong Huang, Xiaojing Shi, Can Feng, Kelong Ai, Yongping Bai   +14 more
doaj   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source